U.S. Physical Therapy, Inc. (NYSE:USPH) Expected to Earn Q3 2024 Earnings of $0.83 Per Share

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at William Blair lifted their Q3 2024 earnings per share estimates for shares of U.S. Physical Therapy in a note issued to investors on Wednesday, May 8th. William Blair analyst J. Haase now anticipates that the company will earn $0.83 per share for the quarter, up from their prior forecast of $0.72. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.77 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.86 EPS, FY2024 earnings at $2.94 EPS, Q1 2025 earnings at $0.63 EPS, Q2 2025 earnings at $0.88 EPS, Q3 2025 earnings at $0.92 EPS, Q4 2025 earnings at $0.94 EPS and FY2025 earnings at $3.36 EPS.

Several other research firms also recently weighed in on USPH. Barrington Research reissued an “outperform” rating and set a $122.00 price target on shares of U.S. Physical Therapy in a research report on Thursday. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Finally, JPMorgan Chase & Co. raised their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and an average target price of $125.67.

U.S. Physical Therapy Price Performance

USPH stock opened at $105.08 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. The stock’s 50 day moving average price is $105.32 and its 200 day moving average price is $96.43. The firm has a market cap of $1.58 billion, a P/E ratio of 77.84, a PEG ratio of 4.99 and a beta of 1.39. U.S. Physical Therapy has a 1 year low of $78.08 and a 1 year high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). The firm had revenue of $155.70 million during the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business’s revenue was up 4.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 EPS.

Institutional Trading of U.S. Physical Therapy

Hedge funds and other institutional investors have recently modified their holdings of the business. Northwest Bank & Trust Co purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter worth about $37,000. SRS Capital Advisors Inc. increased its position in shares of U.S. Physical Therapy by 308.0% during the fourth quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock worth $38,000 after acquiring an additional 308 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its holdings in U.S. Physical Therapy by 268.5% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 549 shares of the company’s stock valued at $61,000 after buying an additional 400 shares during the last quarter. Quantbot Technologies LP bought a new stake in U.S. Physical Therapy in the third quarter valued at about $82,000. Finally, Principal Securities Inc. bought a new stake in U.S. Physical Therapy in the fourth quarter valued at about $100,000.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.26, for a total value of $260,650.00. Following the transaction, the director now directly owns 5,780 shares of the company’s stock, valued at $602,622.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.26, for a total value of $260,650.00. Following the transaction, the director now directly owns 5,780 shares of the company’s stock, valued at $602,622.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Eric Joseph Williams sold 1,500 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.96, for a total value of $157,440.00. Following the completion of the transaction, the insider now directly owns 19,314 shares in the company, valued at $2,027,197.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,829 shares of company stock worth $1,141,535. 1.70% of the stock is owned by insiders.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Thursday, May 23rd will be issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date of this dividend is Wednesday, May 22nd. U.S. Physical Therapy’s payout ratio is currently 130.37%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.